| ²é¿´: 710 | »Ø¸´: 3 | ||
»ôhuixia½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
2-(2-±½ÒÒ»ù)ɫͪÀ࣬º¬Óм×Ñõ»ù ÒÑÓÐ1È˲ÎÓë
|
| 33.96,36.93,56.58,101.36,110.44,115.93,117.94,127.45,127.49,129.44,129.44,129.57,129.57,141.29,159.95,166.20,171.06,180.04 |
» ²ÂÄãϲ»¶
281Çóµ÷¼Á£¨0805£©
ÒѾÓÐ8È˻ظ´
»·¾³ÁìÓòÈ«¹úÖØµãʵÑéÊÒÕÐÊÕ²©Ê¿1-2Ãû
ÒѾÓÐ3È˻ظ´
²ÄÁÏר˶306Ó¢Ò»Êý¶þ
ÒѾÓÐ10È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸Ìì½ò´óѧ»¯Ñ§¹¤ÒÕרҵ£¨081702£©315·ÖÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
302Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
26²©Ê¿ÉêÇë
ÒѾÓÐ3È˻ظ´
268Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
311Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
±»ÎÒÑÔÖУºÐÂÄ£°å²»Ç¿µ÷¸ñʽÁË£¬¼Ùר¼Ò¿ªÊ¼¹Ü¸ñʽÁË
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
4-ÂÈ-4'-¼×Ñõ»ù¶þ±½ÍªÍѼ׻ù
ÒѾÓÐ4È˻ظ´
ÐÂÊÖÇóÖú£¬¹ØÓÚ¶ÔôÇ»ù±½¼×È©ºÍ2-¼×Ñõ»ùÒÒÑõ»ù¼×»ùÂȵķ´Ó¦
ÒѾÓÐ14È˻ظ´
2£¬4-¶þÏõ»ùÂȱ½ÄÜ·ñºÍ¼×Ñõ»ùÄÆ·´Ó¦Éú³É2£¬4-¶þÏõ»ù±½Ñõ¼×ÃÑ£¿
ÒѾÓÐ4È˻ظ´
3-ÒÒÑõ»ù-2-¼×Ñõ»ù±½¼×È©ÐγÉÑǰ·µÄ¹ý³Ì
ÒѾÓÐ4È˻ظ´
ÓÐûÓÐ˺ϳɹý2-µâ-4-¼×Ñõ»ù±½°·
ÒѾÓÐ6È˻ظ´
2-ôÇ»ù-4-¼×Ñõ»ù-¶þ±½¼×ͪºÍ³ôÑõÈÜÒº·´Ó¦
ÒѾÓÐ4È˻ظ´
EDCI TEA DMAPÄÜ´ß»¯±½±ûͪËáÓë¶þ¼×»ù°·µÄõ£°·»¯Âð£¿
ÒѾÓÐ7È˻ظ´
¹ØÓÚN-¼×»ùßÁ¿©ÍéͪµÄÎÊÌâ
ÒѾÓÐ12È˻ظ´
2£¬4-¶þôÇ»ù±½ÒÒͪaäå´ú·´Ó¦ÈçºÎ×ö
ÒѾÓÐ8È˻ظ´
2,2-¶þ¼×Ñõ»ù±ûÍé±£»¤ÁÙ¶þ·Ó
ÒѾÓÐ16È˻ظ´
DMF £¨N,N-¶þ¼×»ù¼×õ£°·£©ÄܺÍȩͪ·´Ó¦Éú³ÉÏ£·ò¼î£¬¼´Ñǰ·Âð£¿
ÒѾÓÐ5È˻ظ´
3-¼×»ù-2-¶¡ÍªµÄºÏ³É·½·¨
ÒѾÓÐ5È˻ظ´
ÇóÖú1-±ûÑõ»ù-2-¼×Ñõ»ù±½Óë±ûõ£ÂÈ·´Ó¦ÎÊÌâ
ÒѾÓÐ3È˻ظ´
ÇóÖú£º7-¼×Ñõ»ù-ÝÁÂúͪµÄºÏ³É
ÒѾÓÐ5È˻ظ´
2,4-¶þôÇ»ù±½ÒÒͪµÄ±£»¤ÎÊÌâ
ÒѾÓÐ16È˻ظ´
ÇóÖú2-ôǼ׻ù»·¼ºÍªµÄºÏ³É
ÒѾÓÐ5È˻ظ´
¡¾ÇóÖú¡¿Ò»¸öÑǼ׻ùÑõ»¯³ÉͪµÄ·´Ó¦
ÒѾÓÐ8È˻ظ´
¡¾ÇóÖú¡¿Çë½ÌÒ»¸ö¹ØÓÚN-¼×»ùßÁ¿©ÍéͪµÄÎÊÌâ
ÒѾÓÐ12È˻ظ´
seuseasoar
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 2238 (½²Ê¦)
- ½ð±Ò: 48079.9
- ºì»¨: 52
- Ìû×Ó: 6730
- ÔÚÏß: 546.4Сʱ
- ³æºÅ: 2400995
- ×¢²á: 2013-04-01
- ÐÔ±ð: MM
- רҵ: ʳƷ¿ÆÑ§»ù´¡
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
|
1 . N-(4-Fluorobenzyl)-4-hydroxy-2-(4-(diphenylmethylidene) piperidin-1-yl)butanamide C29H31FN2O2 ÏàËÆ¶È:64.7% Bioorganic & Medicinal Chemistry 2013 21 5154-5167 2-Substituted 4-hydroxybutanamides as potential inhibitors of ¦Ã-aminobutyric acid transporters mGAT1¨CmGAT4: Synthesis and biological evaluation Paula Kowalczyk, Kinga Sałat, Georg C. Höfner, Natalia Guzior, Barbara Filipek, Klaus T. Wanner, Katarzyna Kulig Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 2 . (2S,4S,5R)-1-benzoyl-4-hydroxy-5-(3-methoxyphenyl)-N,N-dimethylpyrrolidine-2-carboxamide C21H24N2O4 ÏàËÆ¶È:63.1% Tetrahedron 2012 68 2579-2589 Electroreductive five- and six-membered cyclization of aromatic ¦Â- and ¦Ã-imino esters derived from (S)-aspartic acid and (S)-glutamic acid Yosei Takenaga, Yujiro Umesaki, Toshihiko Sakurai, Naoki Kise Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 3 . E-7-methoxy-3-(4-pyridinylmethylene)flavanone ÏàËÆ¶È:61.1% Bioorganic & Medicinal Chemistry Letters 2002 12 1059-1061 New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-Substituted flavanone derivatives Christelle Pouget, Catherine Fagnere, Jean-Philippe Basly, Gerard Habrioux, Albert-Jos¨¦ Chulia Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 4 . (+)-(3aR,6aR)-3a-bromodifluoromethyl-5-methyl-6,6-diphenyl-2-ethylperhydropyrrolo-[3,4-C]pyrrole-1,3,4-trione C22H19BrF2N2O3 ÏàËÆ¶È:61.1% Russian Journal of Organic Chemistry 2002 38 1647-1654 1,3-Dipolar Cycloaddition of Azomethine Ylides Generated from Ketimines and Difluorocarbene to Symmetrically Substituted Olefins M. S. Novikov, A. F. Khlebnikov and R. R. Kostikov Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 5 . methyl 2-((4R,7S) (Rec)-2-amino-3-cyano-5-oxo-7-phenyl-4-(trifluoromethyl)-5,6,7,8-tetrahydro-4H-chromen-4-yl)acetate C20H17F3N2O4 ÏàËÆ¶È:61.1% Tetrahedron 2013 69 6121-6128 Three-component synthesis of 2-amino-3-cyano-5-oxo-4-perfluoroalkyl-5,6,7,8-tetrahydro-4H-chromene derivatives Linglin Bian, Jiechao Xu, Liqing Xie, Jie Chen, Hongmei Deng, Min Shao, Tianling Ding, Hui Zhang, Weiguo Cao Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 6 . N-[3-(4-Benzyloxyphenyl)acryloyl]aspartic acid dimethyl ester C22H23NO6 ÏàËÆ¶È:61.1% Bioorganic & Medicinal Chemistry 1999 7 2391-2395 Aromatic carboxylic acids as farnesyl surrogates in farnesylpyrophosphate-based farnesyltransferase inhibitors Martin Schlitzer, Isabel Sattler Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 7 . compound 19d ÏàËÆ¶È:61.1% Bioorganic & Medicinal Chemistry 2013 21 5154-5167 2-Substituted 4-hydroxybutanamides as potential inhibitors of ¦Ã-aminobutyric acid transporters mGAT1¨CmGAT4: Synthesis and biological evaluation Paula Kowalczyk, Kinga Sałat, Georg C. Höfner, Natalia Guzior, Barbara Filipek, Klaus T. Wanner, Katarzyna Kulig Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 8 . 2-(2-(Cyclohexylamino)-2-(4-methoxyphenylimino)-1-phenylethyl)-1,3-dioxo-2,3-dihydro-1H-inden-2-ide C30H30N2O3 ÏàËÆ¶È:60% Tetrahedron 2012 68 3868-3874 Isocyanide-based four-component synthesis of 1,3-indandionylamidinium betaines Roya Akbarzadeh, Tayebeh Amanpour, Hamid Reza Khavasi, Ayoob Bazgir Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 9 . Compound 7 ÏàËÆ¶È:58.8% Magnetic Resonance in Chemistry 2009 47 1101-1109 NMR and conformational studies of new 5-phenylpyrrole-carboxamide derivatives (pages 1101¨C1109) Luisa C. L¨®pez-Cara, M. Jos¨¦ Pineda de las Infantas, M. Dora Carri¨®n, M. Encarnaci¨®n Camacho, Miguel A. Gallo, Antonio Espinosa and Antonio Entrena Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 10 . 5-hydroxy-8-methoxy-3-phenylnaphtho[2,3-d]isoxazole-4,9-one C18H11NO5 ÏàËÆ¶È:58.8% Heterocycles 2000 53 1029-1040 Polycyclic Hydroxyquinones. Part 31. Regioselective Reactions of 6-Ethylsulfonyl-3-phenylfuro[3,4-d ]isoxazol-4(6H )-one Anion with Quinone Monoketals. Application to the Preparation of Heteroanthracyclinone Analogues Raquel Alguacil, M. Victoria Mart¨ªn, and M. Carmen Paredes* Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 11 . 9-furan-2-yl-9H-phenalen-1-ol C17H12O2 ÏàËÆ¶È:58.8% Bioorganic & Medicinal Chemistry 2010 18 4530-4534 Synthesis and in vitro antiprotozoal evaluation of substituted phenalenone analogues Laura I. Rosquete, M. Gabriela Cabrera-Serra, Jos¨¦ E. Piñero, Patricia Mart¨ªn-Rodr¨ªguez, Leandro Fern¨¢ndez-P¨¦rez, Javier G. Luis, Grant McNaughton-Smith, Teresa Abad-Grillo Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 12 . ethyl 1,4-dihydro-1-(4-methoxyphenyl)-4-oxo-3-quinolinecarboxylate C19H17NO4 ÏàËÆ¶È:58.8% Journal of Heterocyclic Chemistry 2011 48 620-625 Ethyl 1,4-dihydro-4-oxo-3-quinolinecarboxylates by a tandem addition-elimination-SNAr reaction Richard A. Bunce, Eric J. Lee and Matthew T. Grant Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 13 . 1-(4-methoxybenzyl)-2-phenyl-4-pyridone C19H17NO2 ÏàËÆ¶È:58.8% Tetrahedron 2013 69 1387-1396 Regioselective arylation of uracil and 4-pyridone derivatives via copper(I) bromide mediated C¨CH bond activation Chien Cheng, Yu-Chiao Shih, Hui-Ting Chen, Tun-Cheng Chien Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ |

2Â¥2014-12-08 16:01:48
»ôhuixia
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1338.3
- Ìû×Ó: 58
- ÔÚÏß: 14.3Сʱ
- ³æºÅ: 2700147
- ×¢²á: 2013-10-05
- ÐÔ±ð: MM
- רҵ: ÖÐҩѧ
3Â¥2014-12-15 17:56:20
seuseasoar
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 2238 (½²Ê¦)
- ½ð±Ò: 48079.9
- ºì»¨: 52
- Ìû×Ó: 6730
- ÔÚÏß: 546.4Сʱ
- ³æºÅ: 2400995
- ×¢²á: 2013-04-01
- ÐÔ±ð: MM
- רҵ: ʳƷ¿ÆÑ§»ù´¡
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
»ôhuixia: ½ð±Ò+10, ¡ï¡ï¡ïºÜÓаïÖú, лл£¡ 2014-12-29 10:38:03
»ôhuixia: ½ð±Ò+10, ¡ï¡ï¡ïºÜÓаïÖú, лл£¡ 2014-12-29 10:38:03
|
. E-7-methoxy-3-(4-pyridinylmethylene)flavanone ÏàËÆ¶È:61.1% Bioorganic & Medicinal Chemistry Letters 2002 12 1059-1061 New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-Substituted flavanone derivatives Christelle Pouget, Catherine Fagnere, Jean-Philippe Basly, Gerard Habrioux, Albert-Jos¨¦ Chulia Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 2 . methyl 2-((4R,7S) (Rec)-2-amino-3-cyano-5-oxo-7-phenyl-4-(trifluoromethyl)-5,6,7,8-tetrahydro-4H-chromen-4-yl)acetate C20H17F3N2O4 ÏàËÆ¶È:61.1% Tetrahedron 2013 69 6121-6128 Three-component synthesis of 2-amino-3-cyano-5-oxo-4-perfluoroalkyl-5,6,7,8-tetrahydro-4H-chromene derivatives Linglin Bian, Jiechao Xu, Liqing Xie, Jie Chen, Hongmei Deng, Min Shao, Tianling Ding, Hui Zhang, Weiguo Cao Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 3 . N-[3-(4-Benzyloxyphenyl)acryloyl]aspartic acid dimethyl ester C22H23NO6 ÏàËÆ¶È:61.1% Bioorganic & Medicinal Chemistry 1999 7 2391-2395 Aromatic carboxylic acids as farnesyl surrogates in farnesylpyrophosphate-based farnesyltransferase inhibitors Martin Schlitzer, Isabel Sattler Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 4 . N-(4-Fluorobenzyl)-4-hydroxy-2-(4-(diphenylmethylidene) piperidin-1-yl)butanamide C29H31FN2O2 ÏàËÆ¶È:61.1% Bioorganic & Medicinal Chemistry 2013 21 5154-5167 2-Substituted 4-hydroxybutanamides as potential inhibitors of ¦Ã-aminobutyric acid transporters mGAT1¨CmGAT4: Synthesis and biological evaluation Paula Kowalczyk, Kinga Sałat, Georg C. Höfner, Natalia Guzior, Barbara Filipek, Klaus T. Wanner, Katarzyna Kulig Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 5 . compound 19d ÏàËÆ¶È:61.1% Bioorganic & Medicinal Chemistry 2013 21 5154-5167 2-Substituted 4-hydroxybutanamides as potential inhibitors of ¦Ã-aminobutyric acid transporters mGAT1¨CmGAT4: Synthesis and biological evaluation Paula Kowalczyk, Kinga Sałat, Georg C. Höfner, Natalia Guzior, Barbara Filipek, Klaus T. Wanner, Katarzyna Kulig Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 6 . 2-(2-(Cyclohexylamino)-2-(4-methoxyphenylimino)-1-phenylethyl)-1,3-dioxo-2,3-dihydro-1H-inden-2-ide C30H30N2O3 ÏàËÆ¶È:60% Tetrahedron 2012 68 3868-3874 Isocyanide-based four-component synthesis of 1,3-indandionylamidinium betaines Roya Akbarzadeh, Tayebeh Amanpour, Hamid Reza Khavasi, Ayoob Bazgir Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 7 . ailanthamide(minor) C19H21NO3 ÏàËÆ¶È:57.8% Journal of Natural Products 2009 72 107-111 Amides and Benzenoids from Zanthoxylum ailanthoides with Inhibitory Activity on Superoxide Generation and Elastase Release by Neutrophils Jih-Jung Chen, Ching-Yi Chung, Tsong-Long Hwang, and Jinn-Fen Chen Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 8 . 6,7-dimethoxy-2-(2-phenylethyl)chromone C19H18O4 ÏàËÆ¶È:57.8% Chemical & Pharmaceutical Bulletin 1982 30 3791-3795 Studies on the Agarwood (Jinko). I. Structures of 2-(2-Phenylethyl) chromone Derivatives YASUO SHIMADA,TAKAE TOMINAGA,TENJI KONISHI and SHIU KIYOSAWA Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 9 . 3-(4-fluorophenyl)-2-oxo-1,2,3,4-tetrahydrobezo[f]quin-olin-3-carbonyl urea C21H16FN3O3 ÏàËÆ¶È:57.8% Journal of Heterocyclic Chemistry 2007 44 441-447 A new synthesis method for benzo[f]quinolin-3-carbonyl urea and thiourea derivatives in aqueous media catalyzed by TEBAC Xiang-Shan Wang,Mei-Mei Zhang,Zhao-Sen Zeng,Da-Qing Shi,Shu-Jiang Tu,Xian-Yong Wei and Zhi-Min Zong Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 10 . 2-oxo-3-phenyl-1,2,3,4-tetrahydrobezo[f]quinolin-3-carb-onyl thiourea C21H17N3O2S ÏàËÆ¶È:57.8% Journal of Heterocyclic Chemistry 2007 44 441-447 A new synthesis method for benzo[f]quinolin-3-carbonyl urea and thiourea derivatives in aqueous media catalyzed by TEBAC Xiang-Shan Wang,Mei-Mei Zhang,Zhao-Sen Zeng,Da-Qing Shi,Shu-Jiang Tu,Xian-Yong Wei and Zhi-Min Zong Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 11 . 4-(2,4-Diphenyl-7H-pyrrolo[2,3-d]pyrimidin-7-yl)benzonitrile C25H16N4 ÏàËÆ¶È:57.8% Tetrahedron 2012 68 329-339 Synthesis of 4-aryl-, 2,4-diaryl- and 2,4,7-triarylpyrrolo[2,3-d]pyrimidines by a combination of the Suzuki cross-coupling and N-arylation reactions Jelena Dodonova, Lina Skardziute, Karolis Kazlauskas, Saulius Jursenas, Sigitas Tumkevicius Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 12 . (2S,4S,5R)-1-benzoyl-4-hydroxy-5-(3-methoxyphenyl)-N,N-dimethylpyrrolidine-2-carboxamide C21H24N2O4 ÏàËÆ¶È:57.8% Tetrahedron 2012 68 2579-2589 Electroreductive five- and six-membered cyclization of aromatic ¦Â- and ¦Ã-imino esters derived from (S)-aspartic acid and (S)-glutamic acid Yosei Takenaga, Yujiro Umesaki, Toshihiko Sakurai, Naoki Kise Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 13 . 3'-[3-(3-methoxyphenyl)-1-methyl-1H-1,2,4-triazol-5-yl]-biphenyl-4-ol C22H19N3O2 ÏàËÆ¶È:57.8% Archiv der Pharmazie 2012 345 610-621 Synthesis and Biological Evaluation of Phenyl Substituted 1H-1,2,4-Triazoles as Non-Steroidal Inhibitors of 17¦Â-Hydroxysteroid Dehydrogenase Type 2 Yaseen A. Al-Soud, Sandrine Marchais-Oberwinkler, Martin Frotscher and Rolf W. Hartmann Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 14 . (Z)-2-(4-((2,4-dioxothiazolidin-5-ylidene)methyl)phenoxy)-N-methyl-N-phenylacetamide ÏàËÆ¶È:57.8% Archiv der Pharmazie 2012 345 517-524 Synthesis and Evaluation of 5-Benzylidenethiazolidine-2,4-dione Derivatives for the Treatment of Non-Alcoholic Fatty Liver Disease Liang Ma, Jinying Chen, Xiaolin Liang, Caifei Xie, Chongyang Deng, Li Huang, Aihua Peng, Yuanquan Wei and Lijuan Chen Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ 15 . anti-1-benzyl-3-fluoro-3-(3-methoxyphenyl)-4-phenylazetidin-2-one C23H20FNO2 ÏàËÆ¶È:57.8% Tetrahedron 2013 69 1559-1565 Ni-catalyzed ¦Á-arylation of secondary ¦Á-bromo-¦Á-fluoro-¦Â-lactam: cross-coupling of a secondary fluorine-containing electrophile Atsushi Tarui, Shoji Kondo, Kazuyuki Sato, Masaaki Omote, Hideki Minami, Yoshihisa Miwa, Akira Ando Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ |

4Â¥2014-12-15 17:59:41













»Ø¸´´ËÂ¥